Why Investors Were Hot on Oracle Stock Today

The Motley Fool
Updated
Mitrade
coverImg
Source: Shutterstock

On Tuesday, database king Oracle (NYSE: ORCL), hardly for the first time, was an outperformer on the stock market. The company's shares ticked nearly 3% higher on the day, thanks to a report of a potentially major tie-up in the artificial intelligence (AI) field with a top tech sector peer. That rise topped the nearly 1% gain of the S&P 500 index on the day.


OpenAI and Oracle apparently in discussions for AI hardware


According to a report from tech industry news site The Information, leading AI solutions developer OpenAI is discussing a deal with Oracle. Citing an unnamed "person who heard the remarks," the former company's management told certain employees that OpenAI "would play a greater role in lining up data centers and AI chips" to advance the technology, rather than depending entirely on its partner Microsoft to do so.


The article stated that OpenAI is dissatisfied with the speed at which Microsoft is supplying it with servers. AI is resource-intensive, and requires significant amounts of processing power and storage. Microsoft is a major investor in OpenAI, having poured billions of dollars into the company.


Neither Oracle nor Microsoft or OpenAI has yet officially commented on this report.


It's only speculation at this point


If the article is accurate, Oracle stands in front of an exciting and potentially very lucrative business opportunity with OpenAI (developer of the most high-profile commercial AI program, ChatGPT). If these discussions are occurring, they are at an early stage, however, and investors should not pile into Oracle stock on that basis alone.


Should you invest $1,000 in Oracle right now?


Before you buy stock in Oracle, consider this:


The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Oracle wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.


Consider when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $782,682!*


Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month. The Stock Advisor service has more than quadrupled the return of S&P 500 since 2002*.


See the 10 stocks »


*Stock Advisor returns as of October 7, 2024


Eric Volkman has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Microsoft and Oracle. The Motley Fool recommends the following options: long January 2026 $395 calls on Microsoft and short January 2026 $405 calls on Microsoft. The Motley Fool has a disclosure policy.

* The content presented above, whether from a third party or not, is considered as general advice only.  This article should not be construed as containing investment advice, investment recommendations, an offer of or solicitation for any transactions in financial instruments.

goTop
quote
Do you find this article useful?
Related Articles
placeholder
After downgrading Amazon, Wells Fargo says buy Microsoft stockInvesting.com -- After downgrading Amazon (NASDAQ:AMZN) this week, Wells Fargo (NYSE:WFC) said it is increasing its Microsoft (NASDAQ:MSFT) position, recommending investors focus on the tech giant as part of its "Signature Picks" portfolio.
Author  Investing.com
2 hour ago
Investing.com -- After downgrading Amazon (NASDAQ:AMZN) this week, Wells Fargo (NYSE:WFC) said it is increasing its Microsoft (NASDAQ:MSFT) position, recommending investors focus on the tech giant as part of its "Signature Picks" portfolio.
placeholder
MBX Biosciences earns Buy rating at three investment firmsInvesting.com -- Three major investment firms started research coverage of MBX Biosciences stock on Tuesday, each assigning a Buy rating to the biotechnology company.
Author  Investing.com
2 hour ago
Investing.com -- Three major investment firms started research coverage of MBX Biosciences stock on Tuesday, each assigning a Buy rating to the biotechnology company.
placeholder
Nvidia Stock Rallied (Again) Today and Is Near a New All-Time High. Is the Stock Still a Buy?Nvidia (NASDAQ: NVDA) stock has started off October with a bang. After suffering through an epic meltdown over the summer, things are beginning to look up.
Author  The Motley Fool
2 hour ago
Nvidia (NASDAQ: NVDA) stock has started off October with a bang. After suffering through an epic meltdown over the summer, things are beginning to look up.
placeholder
These 2 stocks will trade in a volatile fashion during Tesla's robotaxi eventInvesting.com -- As Tesla (NASDAQ:TSLA) prepares for its highly anticipated robotaxi event, analysts at RBC Capital expect volatility in the stock prices of ride-sharing giants Uber (NYSE:UBER) and Lyft (NASDAQ:LYFT).
Author  Investing.com
2 hour ago
Investing.com -- As Tesla (NASDAQ:TSLA) prepares for its highly anticipated robotaxi event, analysts at RBC Capital expect volatility in the stock prices of ride-sharing giants Uber (NYSE:UBER) and Lyft (NASDAQ:LYFT).
placeholder
1 Growth Stock Down 55% to Buy Right NowIf you're looking for a bargain-priced growth opportunity, look no further than Shopify (NYSE: SHOP). Although shares are up more than 200% from their late 2022 low, they're also still down 55% from their 2021 peak. More importantly, they're currently chugging higher for all the right reasons.
Author  The Motley Fool
Yesterday 02: 38
If you're looking for a bargain-priced growth opportunity, look no further than Shopify (NYSE: SHOP). Although shares are up more than 200% from their late 2022 low, they're also still down 55% from their 2021 peak. More importantly, they're currently chugging higher for all the right reasons.